Brigham and Women's Hospital Cartilage Repair Center Boston, United States of America
We are using cookies to give you the best experience on our site. Cookies are files stored in your browser and are used by most websites to help personalise your web experience. By continuing to use our website without changing the settings, you are agreeing to our use of cookies.
x
To develop and maintain relationships with industry members and with world regulatory agencies to address issues related to cartilage repair
The committee shall consist of at least 6 members and not more than 8. At least one member will be an Industry representative ad at least one other member should be a Non-physician, Scientist member.
Brigham and Women's Hospital Cartilage Repair Center Boston, United States of America
University of California, San Diego Orthopaedic Surgery San Diego, United States of America
University Hospital Regensburg Department of Trauma Surgery Regensburg, Germany
University of Pennsylvania Department of Orthopaedic Surgery Philadelphia, United States of America
CartiHeal Kfar Saba, Israel
Hasharon Hospital Orthopedics PetahTikwa, Israel
Vienna, Austria
Athens, Greece
Devise and disseminate an ICRS consensus opinion on regulatory matters confronting World Regulatory agencies regarding Cell therapies and scaffold Technology. Develop and maintain relationships with Regulatory bodies such as the FDA , EMEA, AMA and other world regulatory bodies. Host and develop joint meetings including regulators, industry representatives, scientists and physicians for the purpose of maintaining lines of communication and fostering better understanding between the various stakeholders. Develop and maintain relationships with Industry members and aide Scientific Program Committee and Executive Director in fostering sponsorship opportunities for the Society and its Scientific Program meeting
The committee members and Chair will be elected and serve as delineated in the Election Procedures.